Optimal control and cost-effectiveness analysis for the human melioidosis model
Habtamu Ayalew Engida1, Duncan Kioi Gathungu2, Melkamu Molla Ferede3
1Department of Applied Mathematics, Debre Markos University, P.O. Box 269, Debre Markos, Ethiopia.
This study models melioidosis control using time-dependent strategies. Strategy C effectively reduced infections, while Strategy B (treatment) proved most cost-effective for mitigating melioidosis spread.
Area of Science:
- Epidemiology
- Mathematical Modeling
- Public Health
Background:
- Melioidosis poses a significant public health challenge.
- Understanding epidemic dynamics is crucial for effective control.
- Optimal control strategies can enhance disease management.
Purpose of the Study:
- To formulate and investigate an optimal control problem for the melioidosis epidemic.
- To evaluate the effectiveness of time-dependent control functions.
- To identify the most effective and cost-effective control strategies.
Main Methods:
- Utilized the next-generation matrix approach to calculate the basic reproduction number with controls.
- Applied Pontryagin's maximum principle to derive the optimality system.
- Simulated the optimality system using the forward-backward sweep method with MATLAB.
Main Results:
- Strategy C demonstrated superior effectiveness in reducing infectious cases compared to Strategies A and B.
- Numerical simulations illustrated the impact of various control interventions on transmission dynamics.
- Cost-effectiveness analysis identified Strategy B (treatment) as the most recommended for disease mitigation.
Conclusions:
- Time-dependent control functions are effective in managing melioidosis spread.
- Strategy C offers the highest reduction in infectious individuals.
- Strategy B is the most cost-effective approach for melioidosis control.
More Related Videos
07:27Simplified Whole Body Plethysmography to Characterize Lung Function During Respiratory Melioidosis
Published on: February 24, 2023
06:19Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections
Published on: October 11, 2024
